Back
Intra-Cellular Therapies Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
38
ITCI
Intra-Cellular Therapies
Last Price:
77.09
Seasonality Move:
27.94%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.79 | Buy |
| 20-day SMA: | 74.15 | Buy |
| 50-day SMA: | 74.47 | Buy |
| 200-day SMA: | 71.38 | Buy |
| 8-day EMA: | 75.95 | Buy |
| 20-day EMA: | 74.93 | Buy |
| 50-day EMA: | 74.5 | Buy |
| 200-day EMA: | 70.77 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 58.08 | Buy |
| Chaikin Money Flow: | -3459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.66 - 76.4) | Buy |
| Bollinger Bands (100): | (70.6 - 77.3) | Buy |
Intra-Cellular Therapies Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 77.09 while ITCI 8-day simple moving average is 75.79, which is a Buy signal.
- The stock price of ITCI is 77.09 while Intra-Cellular Therapies 20-day SMA is 74.15, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 74.47 while ITCI share price is 77.09, making it a Buy technically.
- ITCI stock price is 77.09 and Intra-Cellular Therapies 200-day simple moving average is 71.38, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $77.09. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
8.15B
Price in USD:
77.09
Share Volume:
321.7K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
38
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 77.09 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 77.09 while ITCI 8-day exponential moving average is 75.95, which is a Buy signal.
- The stock price of ITCI is 77.09 while Intra-Cellular Therapies 20-day EMA is 74.93, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 74.50 while ITCI share price is 77.09, making it a Buy technically.
- ITCI stock price is 77.09 and Intra-Cellular Therapies 200-day simple moving average is 70.77, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 58.08, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (72.66 - 76.4), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (70.6 - 77.3), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.